ArticleJournal of Cancer2026

Molecular Signature of Cisplatin Resistance in Ovarian Cancer Identifies Therapeutic Opportunities for Re-sensitization.

Mahmoud Mansour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.